Geneos Wealth Management’s Danimer Scientific, Inc. DNMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-151
Closed -$2.72K 2983
2024
Q3
$2.72K Sell
151
-82
-35% -$1.43K ﹤0.01% 2228
2024
Q2
$5.58K Sell
233
-4
-2% -$124 ﹤0.01% 1694
2024
Q1
$10.3K Hold
237
﹤0.01% 1540
2023
Q4
$9.67K Sell
237
-15
-6% -$816 ﹤0.01% 1558
2023
Q3
$20.9K Hold
252
﹤0.01% 1358
2023
Q2
$24K Hold
252
﹤0.01% 1313
2023
Q1
$34.8K Hold
252
﹤0.01% 1180
2022
Q4
$18K Hold
252
﹤0.01% 1357
2022
Q3
$29K Sell
252
-116
-32% -$20.7K ﹤0.01% 1213
2022
Q2
$69K Sell
368
-22
-6% -$4K ﹤0.01% 1154
2022
Q1
$91K Buy
390
+90
+30% +$18.2K ﹤0.01% 1130
2021
Q4
$102K Buy
300
+122
+69% +$67.2K ﹤0.01% 1162
2021
Q3
$118K Buy
178
+5
+3% +$3.68K ﹤0.01% 1101
2021
Q2
$183K Buy
173
+34
+24% +$33.9K 0.01% 890
2021
Q1
$142K Buy
139
+1
+0.7% +$1.62K ﹤0.01% 1140
2020
Q4
$212K Buy
+138
New +$74K 0.01% 805

Other funds holding DNMR

Geneos Wealth Management's DNMR Position: Q4 2024 in Review

Geneos Wealth Management sold out of Danimer Scientific, Inc. (DNMR) in Q4 2024, closing a stake of 151 shares — an estimated $2.72K sold.

Geneos Wealth Management first reported a position in DNMR in Q4 2020 and held it in 16 quarters. The position peaked at $212K in Q4 2020. 3 funds tracked by Wall St. Rank hold DNMR as of Q4 2024.

  • Geneos Wealth Management reported no remaining Danimer Scientific, Inc. position as of Q4 2024 after selling out during the quarter.
  • Geneos Wealth Management sold 151 Danimer Scientific, Inc. shares in Q4 2024, an estimated $2.72K.
  • Geneos Wealth Management first reported a position in Danimer Scientific, Inc. in Q4 2020 and held it in 16 quarters.
  • Geneos Wealth Management's Danimer Scientific, Inc. position peaked at $212K in Q4 2020.
  • 3 funds tracked by Wall St. Rank held Danimer Scientific, Inc. as of Q4 2024.

Based on Geneos Wealth Management's 13F filing for Q4 2024, filed 21 Jan 2025.